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Background & aims: Dietary polyphenols have beneﬁcial effects on glucose/lipid metabolism in subjects
at high risk to develop type 2 diabetes; however, the underlying mechanisms are not clear. We aimed to
evaluate: 1) the acute effects of the consumption of a drink rich in polyphenols from red grape pomace
(RGPD) on glucose/insulin and triglyceride responses to a standard meal in healthy individuals, and, 2)
the relationship between plasma levels of phenolic metabolites and metabolic parameters.
Methods: Twelve healthy men, aged 20e40 years participated in a randomized, controlled study
according to a cross-over design. After a 3-day lowepolyphenol diet, all participants consumed, on two
different days and separated by a one week interval, after an overnight fast, a drink rich in polyphenols
(1.562 g gallic acid equivalents (GAE)) or a control drink (CD, no polyphenols), followed after 3 h by a
standard meal (960 kcal, 18% protein, 30% fat, 52% CHO). Blood samples were taken at fasting, 3 h after
the drink, over 5 h after the standard meal and at fasting on the next day to measure plasma concen-
trations of glucose, insulin, triglyceride and phenolic metabolites.
Results: Glycemic and triglyceride post-meal responses were similar after both the RGPD and the control
drink. In contrast, postprandial insulin incremental area (iAUC0e5h) was 31% lower (p < 0.05), insulin
secretion index was 18% lower (p < 0.016) and insulin sensitivity (SI) index was 36% higher (p ¼ 0.037)
after the RGPD compared to CD. Among phenolic metabolites, gallic acid correlated inversely with the
insulin response (r ¼ 0.604; p ¼ 0.032) and positively with the SI index (r ¼ 0.588, p ¼ 0.037).
Conclusions: RGPD consumption acutely reduced postprandial insulin levels and improved insulin
sensitivity. This effect could be likely related to the increase in gallic acid levels. This drink, added to
usual diet, could contribute to increase the daily intake of polyphenols, with potential health beneﬁts.
Clinicaltrials.gov identiﬁer: NCT02865278.
© 2018 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.icine and Surgery, Federico II
taly.
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In recent years, the interest in dietary polyphenols has rapidly
increased, due to their potential to improve several biological
functions, such as oxidative stress, endothelial function, platelet
aggregation, lipid and glucose metabolism [1,2] and, consequently,
to prevent chronic diseases such as cardiovascular disease (CVD),
type 2 diabetes (T2D) and some types of cancer [3e7]. However,ism. All rights reserved.
prove insulin response to a standard meal in healthy individuals: A
Table 1
Characteristics of participants in the study (n ¼ 12).
Age (years) 26±3a
BMI (kg/m2) 26 ± 2
Systolic Blood Pressure (mmHg) 125 ± 11
Diastolic Blood Pressure (mmHg) 77 ± 6
Fasting plasma glucose (mg/dl) 96 ± 3
Fasting plasma insulin (mU/ml) 12 ± 6
Fasting plasma cholesterol (mg/dl) 152 ± 29
Fasting plasma triglycerides (mg/dl) 86 ± 34
Fasting plasma HDL-cholesterol (mg/dl) 39 ± 5
Homa Index 2.8 ± 1.1
a Means ± SD (all such values).
G. Costabile et al. / Clinical Nutrition xxx (xxxx) xxx2most of the available studies have focused on single polyphenol
classes, mainly ﬂavonoids and their subclasses, and have used
pharmacological doses of polyphenols that are difﬁcult to achieve
with the habitual diet [8,9]. Moreover, by this approach, the
healthful effects of polyphenols in free living conditions cannot be
fully appreciated, as they can be better deﬁned when naturally
polyphenol-rich food are consumed. Indeed, a clinical trial per-
formed in subjects with metabolic syndrome has shown that a diet
rich in polyphenols (about 3 g/day), completely derived from nat-
ural foods, exerts beneﬁcial effects on lipid and glucose/insulin
metabolism [10,11].
Grapes and red wine are important sources of ﬂavan-3-ols,
anthocyanins, and resveratrol, which are the most investigated
polyphenols due to their putative cardio-protective and chemo-
preventive effects [12e14]. The beneﬁts of grapes and wine poly-
phenols against cardiovascular diseases seem to be mediated by
their favorable effects on plasma lipid levels, LDL oxidation, and in-
hibition of platelet aggregation, inﬂammation and blood pressure
[15]. Limited data is available so far on the effects of grape poly-
phenols on glucose and insulin metabolism. In acute studies, the
supplementation of grape polyphenols was able to reduce plasma
glucose concentration in both animals and humans [16,17]. An
improvement in glucose metabolism was also observed after a
prolonged supplementation of grape polyphenols in peoplewith the
metabolic syndrome and type 2 diabetes [18e20]. However, so far, a
detailed analysis of the metabolic pathways of the polyphenols
involved in themodulation of glucosemetabolism and insulin action
is not yet available. In fact, as most of the studies investigating the
effects of grape polyphenols on clinical outcomes in humans have
not measured their metabolites, the relation between the poly-
phenol metabolic pathways involved in their clinical effects remains
unclear.
In our previous publication, we reported that the acute intake of
an experimental red grape pomace drink (RGPD) developed by us
and prepared in our laboratory was followed by an increase in the
plasma levels of several phenolic metabolites, indicating that RGPD
polyphenols were absorbed in the intestine and metabolized [21].
In this pilot study, we evaluated the acute effects of the con-
sumption of this RGPD on glucose/insulin and lipid responses to a
standard meal in healthy individuals. In addition, we assessed
the relationship between circulating phenolic metabolites and the
main processes regulating glucose metabolism, i.e., insulin secre-
tion and insulin sensitivity.2. Material and methods
2.1. Participants
Thirty-one men were recruited through advertisings posted at
the Department of Clinical Medicine and Surgery of Federico II
University of Naples. Nine candidates were excluded because they
did not meet the inclusion criteria, i.e., age 20e40 years, BMI
20e30 kg/m2, fasting plasma glucose <110 mg/dL, fasting plasma
triglycerides 200 mg/dL and fasting plasma cholesterol
250 mg/dL. Exclusion criteria were cancer and other known
chronic illnesses, diabetes, regular intensive physical activity
(deﬁned asmore than ﬁve training units/week), renal failure (serum
creatinine>1.7 mg/dL), liver disease, anemia, cardiovascular disease
and any other degenerative diseases, use of drugs able to inﬂuence
glucose and lipid metabolism. Ten of those selected declined to
participate; overall, twelvemenwere studied after providingwritten
informed consent. The main clinical characteristics of the partici-
pants are presented in Table 1. The studywas approved by the Ethics
Committee of the “Federico II” Naples University.Please cite this article as: Costabile G et al., Grape pomace polyphenols im
pilot study, Clinical Nutrition, https://doi.org/10.1016/j.clnu.2018.11.0282.2. Study design
Participants were asked to consume a low-polyphenol diet
during the experimental period (at least 3 days before and 2 days
after the 2 test days) as reported in our previous publication [21]. To
facilitate adherence, the volunteers were given a list of permitted
and forbidden foods. To assess polyphenols intake, participants ﬁlled
in a 3-day food record before each test day. Moreover, they were
instructed to abstain from performing vigorous physical activities
24 h before each test day. The study was conducted with a ran-
domized, controlled, cross-over design (Fig. 1). On the two experi-
mental days, at one-week interval, participants were admitted to the
research center after a 12 h overnight fast, for baseline blood
drawing; thereafter, they consumed in randomorder 250mL of a red
grape pomace drink [RGPD; 24 g of soluble carbohydrates, 92 kcal
and 1562 g of total polyphenols, as gallic acid equivalents (GAE)] or
250 mL of a control drink without polyphenols (CD; 24 g of soluble
carbohydrates, 92 kcal). Randomization was made by a web-based
program. Three hours after RGPD or CD consumption, participants
consumed a standard low-polyphenol meal, consisting of white
bread (150 g), fatless ham (70 g), spreadable cheese (80 g) and
plumcake (33 g) (903 kcal, 18% protein, 30% fat, 52% carbohydrates).
At the end of the test day, participants received another standard
meal (pasta omelet) (905 kcal, 14% protein, 46% fat, 40% carbohy-
drates) to be consumed at 9.00 p.m. for dinner.
2.3. Polyphenol composition of red grape pomace drink
A total of 25 phenolic compoundswere identiﬁed and quantiﬁed
in the RGPD. The retention times and mass spectra of the com-
pounds detected are reported in our previous publication (21). The
250 mL of the RGPD used in this study contained 3.7 mmol of total
polyphenols. Anthocyanins were the most abundant class of
phenolic compounds (70%), followed by ﬂavan-3-ol monomers
(23%) and procyanidins (4%). Small amounts of ﬂavonols, galloyl
glucose, and gallic acid were also present in the drink.
2.4. Blood sampling and analytical methods
Blood samples were collected from an antecubital arm vein at
fasting before RGPD/CD consumption. After 3 h, a standard meal
was administered and blood samples were collected immediately
before and at 30 min intervals for 5 h. In addition, the day after the
test, a fasting sample was also collected in the morning, 24 h after
the test drink.
Blood drawn in EDTA tubes was centrifuged and plasma was
stored at 80 C until the analyses. Plasma glucose and triglyceride
concentrations were assayed by enzymatic colorimetric methods
(ABX Diagnostics, Montpellier, France) on an ABX Pentra 400
Autoanalyzer (ABXDiagnostics,Montpellier, France). Plasma insulin
concentration was measured by sandwich enzyme-linkedprove insulin response to a standard meal in healthy individuals: A
Fig. 1. Study design.
G. Costabile et al. / Clinical Nutrition xxx (xxxx) xxx 3immunosorbent assay methods (ELISA; DIAsource ImmunoAssays
S.A., Nivelles, Belgium; Merck-Millipore, Darmstadt, Germany)
on Triturus Analyzer (Diagnostics Grifols, S.A., Barcelona, Spain).
Plasma phenolic metabolites analysis was performed only in ten
participants by UHPLC-ESI-MS/MS techniques, as reported previ-
ously [21].2.5. Data analysis and statistics
The primary outcome of the present studywas the differences in
insulin sensitivity after RGPD and CD consumption. Due to the
preliminary nature of the study, it was not possible to calculate the
sample size needed to obtain a power greater than 80% with an a
error less than 5%.
All data are expressed as mean ± SEM unless otherwise stated.
The post-meal response of glucose, insulin, triglycerides, poly-
phenols and their metabolites was expressed as incremental area
under the curve above the fasting value (iAUC). Fasting insulin
resistance was assessed by the Homeostatic Model Assessment
(HOMA) method calculated as: [fasting glucose (mg/dl) x fasting
insulin (mU/ml)/405]. The insulin sensitivity index (SI) was calcu-
lated from the meal glucose tolerance test (MGTT) over 2 h
according to Caumo et al. [22].
The insulin secretion index was calculated as ratio between
insulin and glucose total areas under the curve (insulin tAUC 0e5 h)/
(glucose tAUC 0e5 h min).
A repeated measures ANOVA was performed to examine
the effects of RGPD/CD on postprandial glucose, insulin and tri-
glycerides responses. In this analysis, post-meal values measured
after the standard meal were included as levels of the within-
subject “time” factors, and RGPD and CD were included as levels
of the within-subject “drink” factors. Differences between time-
points of post-meal glucose, insulin and triglycerides responses
and the corresponding iAUC, SI index, and Insulin Secretion were
tested by paired sample t-test.Please cite this article as: Costabile G et al., Grape pomace polyphenols im
pilot study, Clinical Nutrition, https://doi.org/10.1016/j.clnu.2018.11.028The associations between plasma phenolic metabolites and the
main clinical outcomes in the participants consuming RGPD were
explored by bivariate associations using Pearson's correlation. A
stepwise linear regression analysis, using themetabolic parameters
as dependent variables and plasma phenolic metabolites as inde-
pendent variables, was also performed to assess the plasma
phenolic metabolites that best predicted the outcomes. The
regressionmodel was also used to test formulticollinearity through
tolerance and variance inﬂation factor (VIF). If the value of toler-
ance was more than 0.2 and, simultaneously, the value of VIF less
than 10, then the multicollinearity was considered not problematic.
For all analyses, the level of statistical signiﬁcance was set at
p ¼ 0.05 (two tails). Statistical analysis was performed using the
SPSS software 20.0 (SPSS/PC; IBM Armonk, NY, USA).3. Results
3.1. Post-meal metabolic response
Glucose, insulin and triglyceride levels at fasting and in response
to the standard meal and the corresponding iAUC are reported in
Fig. 2. On the two experimental days, there were no differences in
fasting values; after RGPD or CD consumption, the post-meal
glucose response was not different (p ¼ 0.299, drink effect;
repeated measures ANOVA), evaluated either at any time point of
the curve or as iAUCs [540 ± 16 vs 549 ± 15 mg/dl  5 h, respec-
tively; p ¼ 0.903] (Fig. 2A). Conversely, post-meal insulin levels
were lower after RGPD than after CD consumption (p¼ 0.025, drink
effect; repeated measures ANOVA), reaching a statistically signiﬁ-
cant difference at 1 and 2 h after the meal (p < 0.05); consistently,
the corresponding iAUCs was signiﬁcantly lower after RGPD than
CD [102 ± 10 vs 148 ± 19 mU/ml  5 h (M±SEM), respectively;
p ¼ 0.036] (Fig. 2B).
Post-meal plasma triglyceride levels were not different after
consuming RGPD or CD (p ¼ 0.675, meal effect; repeated measuresprove insulin response to a standard meal in healthy individuals: A
Fig. 2. Postprandial plasma glucose (A) insulin (B) and triglycerides (C) concentrations and corresponding incremental area under the curve (iAUC) (means ± SEM) after the intake
of the Red Grape Pomace Drink (RGPD) and Control Drink (CD) in young volunteers. xp < 0.05 for drink effect by Repeated Measures ANOVA; *p < 0.05 Different from Control
(Paired sample t-test).
G. Costabile et al. / Clinical Nutrition xxx (xxxx) xxx4ANOVA), either at any time point of the curve or as iAUCs [173 ± 35
vs 141 ± 26mg/dl 5 h, (M±SEM), respectively; p¼ 0.176] (Fig. 2C).
Insulin sensitivity index (SI), over 2 h after the meal, was
signiﬁcantly higher (þ36%) after RGPD as compared to CD intake
[0.34 ± 0.06 vs. 0.25 ± 0.06 mL/min/kg/mU/mL, respectively;
p ¼ 0.037] (Fig. 3). Moreover, the insulin secretion index calculatedPlease cite this article as: Costabile G et al., Grape pomace polyphenols im
pilot study, Clinical Nutrition, https://doi.org/10.1016/j.clnu.2018.11.028over 5 h after the standard meal was signiﬁcantly lower (18%)
after RGPD compared to CD consumption [0.29 ± 0.03 vs.
0.35 ± 0.04 mU/mg, respectively; p ¼ 0.016] (Fig. 3).
Twenty-four hours after the test day, fasting glucose, insulin and
triglyceride concentrations were similar after consumption of
RGPD or CD (glucose: 97 ± 2 vs 98 ± 2 mg/dl; insulin: 11 ± 2 vsprove insulin response to a standard meal in healthy individuals: A
Fig. 3. Insulin Secretion (A) and Insulin Sensitivity (B) Indices (meas±SEM) after the intake of the Red Grape Pomace Drink (RGPD) and Control Drink (CD) in young volunteers.
*p < 0.05 Different from Control (Paired sample t-test).
G. Costabile et al. / Clinical Nutrition xxx (xxxx) xxx 512 ± 1 mU/ml; triglyceride: 81 ± 8 vs 79 ± 12 mg/dl; (M±SEM),
respectively).3.2. Plasma phenolic metabolites
The pharmacokinetic parameters of phenolic metabolites
detected in plasma have been reported previously by Castello et al.
[21]. In particular, up to 28 compounds have been identiﬁed in the
plasma samples following RGPD consumption. For each compound,
the incremental area under the plasma concentration-time curve
(iAUC) over 8 h after RGPD ingestion is reported in Table 2. Phenyl-
g-valerolactones were the most abundant class of phenolicTable 2
Plasma polyphenol metabolites concentrations after red grape pomace drink
consumption.
Polyphenolic compounds iAUC0e8h (nmol h L1)
Simple phenols and hydroxybenzoic acids
Gallic acid 193.5 ± 43.3a
Vanillic acid-4-glucuronide 172.6 ± 25.4
Protocatechuic acid 5.8 ± 2.1
Protocatechuic acid-3-glucuronide 5.2 ± 1.5
Protocatechuic acid-3-sulphate 970.1 ± 134.4
Benzoic acid-4-sulphate 76.8 ± 35.2
Vanillic acid-4-sulphate 205.3 ± 43.8
Catechol-sulphate 4.8 ± 2.4
Methylpyrogallol-sulphate 1394.2 ± 313.7
Methylcatechol-sulphate 136.9 ± 24.5
4-Hydroxyhippuric acid 180.5 ± 62.1
Hydroxyphenylpropionic and hydroxycinnamic acids
Ferulic acid 4-glucuronide 109.4 ± 24.6
Feruloylglycine 19.4 ± 9.3
Dihydrocaffeic acid-sulphate 8.0 ± 2.0
Dihydroferulic acid-sulphate 4.2 ± 1.2
Ferulic acid-4-sulphate 18.7 ± 4.3
(Epi)catechin derivatives
(Epi)catechin-glucuronide-sulphate 12.9 ± 3.4
(Epi)catechin-glucuronide 396.8 ± 33.1
(Epi)catechin-sulphate, isomer 1 146.3 ± 32.3
(Epi)catechin-sulphate, isomer 2 241.5 ± 46.4
Methyl(epi)catechin-sulphate, isomer 1 25.8 ± 3.8
Phenyl-g-valerolactones and phenyl-valeric acids
5-Phenyl-valeric acid-sulphate-glucuronide 26.0 ± 7.6
5-(30-Hydroxyphenyl)-g-valerolactone-40-glucuronide 712.8 ± 166.8
5-(40-Hydroxyphenyl)-g-valerolactone-30-glucuronide 3788.4 ± 826.5
5-(Hydroxyphenyl)-g-valerolactone-sulphate isomers 2634.2 ± 536.3
5-Phenyl-g-valerolactone-30-glucuronide 206.3 ± 103.7
5-Phenyl-g-valerolactone-30-sulphate 141.5 ± 58.6
5-(30 ,40-Dihydroxyphenyl)-g-valerolactone 42.5 ± 11.2
a Means ± SEM (all such values).
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conjugated isomers of 5-(3ʹ,4ʹ-hydroxyphenyl)-g-valerolactone
represented the most abundant compounds (Table 2). A total of 10
hydroxybenzoic acids and simple phenols were detected, being
methylpyrogallol-sulphate, protocatechuic acid-3-sulphate fol-
lowed by vanillic acid-4-sulphate and gallic acid, the most repre-
sentative compounds (Table 2).
Regarding hydroxyphenylpropionic acids and hydroxycinnamic
acids, up to ﬁve compounds were detected in plasma. Ferulic acid-
4-glucuronide was the most abundant compound (Table 2). A total
of 5 epicatechin derivatives were detected in plasma, of which the
most representative was epicatechin-glucuronide, followed by
epicatechin sulphate isomers 1 and 2 (Table 2).
A linear correlation analysis showed that plasma gallic acid
concentration (Gallic Acid iAUC0e8h) was the only phenolic metab-
olite being inversely correlated with post-meal plasma insulin
response (Insulin iAUC0e5h) (r ¼ 0.604, p ¼ 0.032) after RGPD
consumption, and positively with the Insulin Sensitivity Index (SI)
(r ¼ 0.588, p ¼ 0.037) (Fig. 4). No other correlation was statistically
signiﬁcant between any of the phenolic metabolites and insulin
secretion and insulin sensitivity indices.
Stepwise linear regression, using the SI index as dependent
variable and plasma phenolicmetabolites as independent variables,
showed that gallic acid was the best predictor of SI index (b¼ 0,707,
p ¼ 0.033), followed by epicatechin-glucuronide (b ¼ 0,274,
p ¼ 0.001) and dihydrocaffeic acid-sulphate (b ¼ 0,089; p ¼ 0.015).4. Discussion
The most relevant ﬁnding of our study is that the acute con-
sumption of an experimental RGPD rich in polyphenols decreased
post-meal insulin response and improved insulin sensitivity.
Indeed, iAUC0e5h was 31% lower and the SI index was 36% higher
after the RGPD drink compared to CD. Similarly, insulin secretion
index, calculated over 5 h after the standard meal, was 18% lower
after RGPD than after CD.
Insulin sensitivity and insulin secretion have long been
acknowledged as the main processes regulating glucose homeo-
stasis [23]. They are linked by a close and inverse relationship and,
therefore, changes in one process produce adaptation of the other
one. Based on this notion, the lower post-meal insulin secretion
observed in our study after the consumption of the RGPD drink
should be interpreted as a compensatory reciprocal change induced
by the improvement in insulin sensitivity following RGPD. The fact
that post-meal glucose response was similar after both RGDP andprove insulin response to a standard meal in healthy individuals: A
Fig. 4. Correlation between plasma gallic acid concentration (iAUC0e8h) and Postprandial Insulin Response (iAUC0e5h) and Insulin Sensitivity Index (SI).
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supports an improvement of insulin action.
Our ﬁndings are in line with previous studies showing a bene-
ﬁcial effect of grape polyphenols on glucose and insulin meta-
bolism. In particular, a randomized controlled trial showed that the
intake of grape seed extract for 4 weeks decreased fructosamine
levels [19]. Similarly, Banini et al. [20] showed a reduction in fasting
glucose, insulin and glycated hemoglobin after red wine and
dealcoholized wine consumption for 4-week compared to grape
juice. More recently, Urquiaga et al. [18] reported a signiﬁcant
decrease in fasting glucose levels and 2-h OGTT insulinPlease cite this article as: Costabile G et al., Grape pomace polyphenols im
pilot study, Clinical Nutrition, https://doi.org/10.1016/j.clnu.2018.11.028concentrations after a 16-week supplementation with a grape
polyphenol ﬂour in patients at high cardiometabolic risk, with at
least one component of the metabolic syndrome. Our study pro-
vides the novel ﬁnding that the beneﬁcial effects of polyphenols
and their metabolites on glucose homeostasis seem to be attrib-
utable to their ability to improve insulin sensitivity, which is
compensated by a reduction, or down regulation, of b-cell function.
The ﬁnding that RGPD is associated with a lower post-meal
insulin response has important clinical implications in the light of
previous studies showing that postprandial hyperinsulinemia is a
risk factor for the development of T2D and cardiovascular diseasesprove insulin response to a standard meal in healthy individuals: A
G. Costabile et al. / Clinical Nutrition xxx (xxxx) xxx 7[24]. In the medium/long term, an improvement in postprandial
insulin and glucosemetabolism, through a reduction of b cell stress,
might preserve b-cell function and delay the onset of diabetes [25].
An interesting observation of our study is that post-meal levels
of gallic acid were inversely correlated with post-meal plasma in-
sulin response and positively with SI index (Fig. 4). Stepwise linear
regression analysis conﬁrmed gallic acid as the best predictor of SI
index. Based on our knowledge, this is a novel ﬁnding since until
now no clinical trial has shown an association between speciﬁc
phenolic compounds and outcomes related to type 2 diabetes. The
beneﬁt of gallic acid on insulin sensitivity is supported by previous
studies showing that the administration of gallic acid together with
a high-fat diet in diabetic rats induced lower body weight gain,
fasting glucose and insulin levels [26]. In this study, gallic acid
signiﬁcantly enhanced peroxisome proliferator-activated receptor g
(PPARg) expression and activated glucose transporter protein 4
(GLUT4) in adipose tissue, thus improving adipose tissue insulin
sensitivity, modulating adipogenesis and increasing adipose
glucose uptake [26]. In vitro studies on adipocytes also demon-
strated that polyphenols from grapes might improve glucose
uptake, directly inﬂuencing the expression of PPARg and the
translocation of glucose-transported GLUT-4 [27,28]. Finally, poly-
phenols might improve glucose metabolism also through their
action on carbohydrate digestion and insulin secretion [29].
To our knowledge, our study is the ﬁrst one demonstrating, in
humans, an improvement of insulin sensitivity in acute conditions
after polyphenol intake. An improvement in insulin sensitivity has
been previously demonstrated by Bozzetto et al. [11] after 8 weeks
of a naturally polyphenol-rich diet. A novelty of our study is that the
metabolic effects of polyphenols were evaluated 3-h after RGPD
ingestion while in previous studies, polyphenols were generally
administered together with the meal. We chose this timing since
the plasma concentration of different classes of phenolic metabo-
lites peak at different time points [30], as also demonstrated in our
previous publication [21]. Therefore, meal consumption closer to
the expected maximal peak of phenolic metabolites, achieved
3e4 h after drink consumption, is likely to maximize the potential
beneﬁcial effects of these compounds on postprandial metabolic
parameters.
The strengths of our study are the well-controlled design and
the measurement of plasma phenolic metabolites, which allowed
us to explore the relationship between polyphenol consumption
and the metabolic responses.
Finally, for its beneﬁcial effects on glucose metabolism, our
experimental RGPD could be classiﬁed as a functional product to be
recommended to the general population to increase their daily
polyphenol dietary intake. Notably, the sugar content of our RGPD
is very low compared with other fruit juices, especially those based
on grapes; this characteristic represents a further health advantage,
particularly for individuals with abnormal glucose metabolism.
One limitation of our study is the acute nature and the small
sample size, due to the limited availability of RGPD, which was
produced on a small scale in a laboratory setting. Nevertheless,
RGPD was able to improve insulin sensitivity in subjects with
normal glucose homeostasis. Thus, it is conceivable that the
beneﬁcial effect of the RGPD consumption could be even greater
and more evident with a larger sample size.
In conclusion, polyphenols from a RGPD, consumed away from
meal, improve insulin sensitivity and reduce insulin secretion e ef-
fects likely mediated by the increase in plasma levels of gallic acid.
This drink included in the usual diet could contribute to increase the
daily intake of polyphenols with potential health beneﬁts. We have
previously demonstrated that consuming regularly a polyphenol rich
diet containing 3 g polyphenol/day led to a substantial improvement
in glucose tolerance, insulin sensitivity and postprandialPlease cite this article as: Costabile G et al., Grape pomace polyphenols im
pilot study, Clinical Nutrition, https://doi.org/10.1016/j.clnu.2018.11.028triglycerides. During that study, we had to acknowledge the difﬁculty
of the study participants to adhere to the polyphenol rich diet. The
possibility to integrate a diet based on natural rich polyphenol
productswith a drink obtained fromgrapemight allowa reduction in
the amount of natural products consumed daily, thus facilitating a
better long term compliance to polyphenol rich diets.
Further intervention studies are needed to better clarify the
impact of polyphenols and their metabolites on the metabolic
parameters related to type 2 diabetes risk.
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